Antibodies to M-CSF

Details for Australian Patent Application No. 2004275700 (hide)

International Classifications

Event Publications

27 April 2006 PCT application entered the National Phase

PCT publication WO2005/030124 Priority application(s): WO2005/030124

4 May 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 03 Apr 2006

9 November 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Sep 2006

28 August 2008 Alteration of Name

The name of the applicant has been altered to Warner-Lambert Company LLC; Amgen Fremont Inc. 2005

24 September 2009 Application Accepted

Published as AU-B-2004275700

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.